Cargando…

Potential contributions of trace amines in Alzheimer’s disease and therapeutic prospects

Detalles Bibliográficos
Autores principales:	Dhakal, Sudip, Macreadie, Ian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284261/ https://www.ncbi.nlm.nih.gov/pubmed/33318424 http://dx.doi.org/10.4103/1673-5374.300985

Ejemplares similares

Finding effective combinations of compounds to prevent Alzheimer’s disease
por: Dhakal, Sudip, et al.
Publicado: (2022)

Protein Homeostasis Networks and the Use of Yeast to Guide Interventions in Alzheimer’s Disease
por: Dhakal, Sudip, et al.
Publicado: (2020)

Dietary Polyphenols: A Multifactorial Strategy to Target Alzheimer’s Disease
por: Dhakal, Sudip, et al.
Publicado: (2019)

Trans-Chalcone Plus Baicalein Synergistically Reduce Intracellular Amyloid Beta (Aβ(42)) and Protect from Aβ(42) Induced Oxidative Damage in Yeast Models of Alzheimer’s Disease
por: Dhakal, Sudip, et al.
Publicado: (2021)

Tyramine and Amyloid Beta 42: A Toxic Synergy
por: Dhakal, Sudip, et al.
Publicado: (2020)

The Use of Yeast in Biosensing
por: Dhakal, Sudip, et al.
Publicado: (2022)

Trace amine-associated receptors at the cross-road between innate olfaction of amines, emotions, and adult neurogenesis
por: Efimova, Evgeniya V., et al.
Publicado: (2021)

Simvastatin Efficiently Reduces Levels of Alzheimer’s Amyloid Beta in Yeast
por: Dhakal, Sudip, et al.
Publicado: (2019)

hiPSC-based models to decipher the contribution of human astrocytes to Alzheimer’s disease and potential therapeutics
por: TCW, Julia, et al.
Publicado: (2023)

Metabolic recruitment of spinal locomotion: intracellular neuromodulation by trace amines and their receptors
por: Hochman, Shawn
Publicado: (2015)

A Toxic Synergy between Aluminium and Amyloid Beta in Yeast
por: Mcdonald, Jamieson B., et al.
Publicado: (2021)

Diagnostic and therapeutic potential of exosomal miRNAs in Alzheimer’s disease
por: Manna, Ida, et al.
Publicado: (2021)

Using Plants as a Source of Potential Therapeutics for the Treatment of Alzheimer’s Disease
por: Maher, Pamela A.
Publicado: (2020)

The therapeutic potential of mesenchymal stem cells in Alzheimer's disease: converging mechanisms
por: Turgeman, Gadi
Publicado: (2015)

Is EAAT2 a potential therapeutic intervention target for Alzheimer’s disease?
por: Wood, Oliver WG, et al.
Publicado: (2023)

Vascular dysfunction in Alzheimer’s disease: a biomarker of disease progression and a potential therapeutic target
por: Govindpani, Karan, et al.
Publicado: (2019)

Next generation therapeutics for Alzheimer's disease
por: Bredesen, Dale E, et al.
Publicado: (2013)

Heparan sulfate proteoglycans as possible diagnostic molecular tools with therapeutic potential in Alzheimer´s disease
por: Fernández-Vega, Iván, et al.
Publicado: (2020)

Heparan sulfate proteoglycans and heparanases in Alzheimer's disease: current outlook and potential therapeutic targets
por: Lorente-Gea, Laura, et al.
Publicado: (2017)

Therapeutic potential of alpha 5 subunit containing GABA(A) receptors in Alzheimer’s disease
por: Kwakowsky, Andrea, et al.
Publicado: (2021)

Finding chemopreventatives to reduce amyloid beta in yeast
por: Macreadie, Ian G., et al.
Publicado: (2016)

Molecular Mechanisms of Alzheimer’s Disease III
por: Macreadie, Ian G.
Publicado: (2022)

The viral hypothesis: how herpesviruses may contribute to Alzheimer’s disease
por: Wainberg, Michael, et al.
Publicado: (2021)

The Contribution and Therapeutic Potential of Epigenetic Modifications in Alzheimer’s Disease
por: Wood, Ian C.
Publicado: (2018)

Active immunotherapy and alternative therapeutic modalities for Alzheimer's disease
por: Weninger, Stacie, et al.
Publicado: (2020)

Cannabinoid pharmacology and its therapeutic uses in Alzheimer’s disease
por: Monteiro, Kadja Luana Chagas, et al.
Publicado: (2020)

TREM2 as an evolving therapeutic target in Alzheimer’s disease
por: George, Jacob
Publicado: (2023)

On the horizon—the value and promise of the global pipeline of Alzheimer's disease therapeutics
por: Cole, Michael A., et al.
Publicado: (2020)

Estrogens still represent an attractive therapeutic approach for Alzheimer’s disease
por: Tamagno, Elena, et al.
Publicado: (2021)

Neurovascular ageing: transcriptomic readout and implications on therapeutic targeting in Alzheimer's disease
por: Li, Zhongqi, et al.
Publicado: (2021)

CD34(+) progenitor cells as diagnostic and therapeutic targets in Alzheimer’s disease
por: Romaus-Sanjurjo, Daniel, et al.
Publicado: (2022)

Repurposing ibrutinib: therapeutic effects and implications for translational approaches in Alzheimer’s disease
por: Lee, Hyun-ju, et al.
Publicado: (2023)

Targeting calcium signaling in Alzheimer’s disease: challenges and promising therapeutic avenues
por: Song, LinLin, et al.
Publicado: (2023)

Perspective: Is therapeutic plasma exchange a viable option for treating Alzheimer's disease?
por: Imbimbo, Bruno P., et al.
Publicado: (2020)

Abscisic acid, a promising therapeutic molecule to prevent Alzheimer’s and neurodegenerative diseases
por: Sánchez-Pérez, Ana María
Publicado: (2019)

Unraveling the Gordian knot: genetics and the troubled road to effective therapeutics for Alzheimer’s disease
por: Restifo, Linda L
Publicado: (2021)

Melastatin-related transient receptor potential 2 channel in Aβ(42)-induced neuroinflammation: implications to Alzheimer’s disease mechanism and development of therapeutics
por: Wei, Linyu, et al.
Publicado: (2018)

Trace Amines and the Trace Amine-Associated Receptor 1: Pharmacology, Neurochemistry, and Clinical Implications
por: Pei, Yue, et al.
Publicado: (2016)

Transcranial photobiomodulation with near-infrared light: a promising therapeutic modality for Alzheimer’s disease
por: Liu, Hanli, et al.
Publicado: (2023)

Emerging small-molecule therapeutic approaches for Alzheimer's disease and Parkinson's disease based on targeting microRNAs
por: Abdelrahman, Somaya A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ijebt0jkpur4s6veua3cvqp2df